The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Open accessAbstract
BACKGROUND: In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B6 and B12 lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease. METHODS: We randomly assigned 5522 patients 55 years of age or older who had vascular disease or diabetes to daily treatment either with the combination of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12 or with placebo for an average of five years. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, and stroke. RESULTS: Mean plasma homocysteine levels decreased by 2.4 micromol per liter (0.3 mg per liter) in the active-treatment group and increased by 0.8 micromol per liter (0.1 mg per liter) in the placebo group. Primary outcome events occurred in 519 patients (18.8 percent) assigned to active therapy and 547 (19.8 percent) assigned to placebo (relative risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P=0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). CONCLUSIONS: Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Antman, E. M., Bassand, J., Klein, W. W., Ohman, M. E., Sendón, J. L. L., Rydén, L., Simoons, M. L., & Tendera, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00804-4 · Cited by 4,824
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,708
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,945
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., & Schouten, E. G. (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 932
Cited by
Sorted by citations
Items 101–200 of 1,000
Homocysteine – from disease biomarker to disease prevention
Smith, A. D., & Refsum, H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13279 · Cited by 274
Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., & Green, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.511 · Cited by 260
Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability
Saposnik, G., Ray, J. G., Sheridan, P., McQueen, M., Lonn, E., & the HOPE 2 Investigators (2009) · Stroke · doi:10.1161/strokeaha.108.529503 · Cited by 260
Self-citationHomocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials
Antoniades, C. A., Antonopoulos, A. S., Tousoulis, D., Marinou, K., & Stefanadis, C. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn515 · Cited by 258
Dietary supplements and disease prevention — a global overview
Rautiainen, S., Manson, J. E., Lichtenstein, A. H., & Sesso, H. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.54 · Cited by 252
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.012 · Cited by 242
Folate: a magic bullet or a double edged sword for colorectal cancer prevention?
Kim, Y. (2006) · Gut · doi:10.1136/gut.2006.095463 · Cited by 236
Homocysteine, vitamins, and vascular disease prevention
McCully, K. S. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1563s · Cited by 228
Zhang, X., Wu, F., Liu, P., Gu, N., & Chen, Z. (2014) · Small · doi:10.1002/smll.201401658 · Cited by 232
Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114969 · Cited by 223
Homocysteine-lowering therapy: a role in stroke prevention?
Spence, J. D. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70219-3 · Cited by 220
Vascular Oxidant Stress and Inflammation in Hyperhomocysteinemia
Papatheodorou, L., & Weiss, N. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1750 · Cited by 227
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
Vergeer, M., Holleboom, A. G., Kastelein, J. J. P., & Kuivenhoven, J. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001610 · Cited by 222
Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein
Mintzer, S., Skidmore, C. T., Abidin, C. J., Morales, M. C., Chervoneva, I., Capuzzi, D. M., & Sperling, M. R. (2009) · Annals of Neurology · doi:10.1002/ana.21615 · Cited by 221
Wald, D. S., Wald, N., Morris, J. K., & Law, M. (2006) · BMJ · doi:10.1136/bmj.39000.486701.68 · Cited by 215
Chemoprevention of colorectal cancer: systematic review and economic evaluation
Cooper, K. L., Squires, H., Carroll, C., Papaioannou, D. E., Booth, A., Logan, R., Maguire, C., Hind, D., & Tappenden, P. (2010) · Health Technology Assessment · doi:10.3310/hta14320 · Cited by 218
Kietadisorn, R., Juni, R. P., & Moens, A. L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2011 · Cited by 221
Chiang, C., Chang, J. Y., Wang, Y., Wu, Y.-H., Lu, S.-Y., & Sun, A. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.021 · Cited by 216
Sesso, H. D., Christen, W. G., Bubes, V., Smith, J. P., MacFadyen, J., Schvartz, M., Manson, J. E., Glynn, R. J., Buring, J. E., & Gaziano, J. M. (2012) · JAMA · doi:10.1001/jama.2012.14805 · Cited by 208
Homocysteine and Reclassification of Cardiovascular Disease Risk
Veeranna, V., ZALAWADIYA, S. K., Niraj, A., Pradhan, J., Ference, B. A., Burack, R. C., Jacob, S., & Afonso, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.028 · Cited by 213
Conte, S. M., & Vale, P. R. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.10.014 · Cited by 208
Detection of Altered Global DNA Methylation in Coronary Artery Disease Patients
Sharma, P., Kumar, J., Garg, G., Kumar, A., Patowary, A., Karthikeyan, G., Ramakrishnan, L., Brahmachari, V., & Sengupta, S. (2008) · DNA and Cell Biology · doi:10.1089/dna.2007.0694 · Cited by 205
“…significantly reduce the risk of adverse events in cardiovascular disease patients although the levels of homocysteine were substantially reduced (Bonaa et al. , 2006; Lonn et al. , 2006), thus questioning the role of level of vitamin B12 = B6 in preventing adverse effects of homocysteine in CAD.”
Clarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S. J. P. M., Lewerin, C., Stott, D. J., Armitage, J., Hankey, G. J., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076349 · Cited by 206
Cancer risk with folic acid supplements: a systematic review and meta-analysis
Wien, T. N., Pike, E., Wisløff, T. F., Staff, A., Smeland, S., & Klemp, M. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000653 · Cited by 206
Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease
Schmidt, T. S., & Alp, N. J. (2007) · Clinical Science · doi:10.1042/cs20070108 · Cited by 195
Effect of Combined Folic Acid, Vitamin B 6 , and Vitamin B 12 on Cancer Risk in Women
Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.2008.555 · Cited by 195
“There was no increase in risk of colon cancer among women treated with combined B vitamins in the WAFACS trial, but a slightly increased risk was observed in the HOPE-2 trial.(12) However, the number of colon cancer cases was limited in these randomized trials.”
BackgroundRate and determinants of progression of atherosclerosis in systemic lupus erythematosus
Roman, M. J., Crow, M. K., Lockshin, M. D., Devereux, R. B., Paget, S. A., Sammaritano, L. R., Levine, D. M., Davis, A., & Salmon, J. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22924 · Cited by 193
Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients
Bostom, A. G., Carpenter, M. A., Kusek, J. W., Levey, A. S., Hunsicker, L. G., Pfeffer, M. A., Selhub, J., Jacques, P. F., Cole, E., Gravens‐Mueller, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.000588 · Cited by 191
Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats
Chang, L., Geng, B., Yu, F. H. Z., Zhao, J., Jiang, H., Du, J., & Tang, C. (2007) · Amino Acids · doi:10.1007/s00726-007-0011-8 · Cited by 190
Chiang, C., Chang, J. Y., Wang, Y., Wu, Y.-H., Wu, Y., & Sun, A. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.10.023 · Cited by 192
Novel insights on interactions between folate and lipid metabolism
da Silva, R. P., Kelly, K. B., Rajabi, A. A., & Jacobs, R. L. (2013) · BioFactors · doi:10.1002/biof.1154 · Cited by 193
Homocysteine and the pathogenesis of atherosclerosis
McCully, K. S. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1010516 · Cited by 187
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185752 · Cited by 185
Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease
Kendrick, J., & Chonchol, M. B. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0954 · Cited by 187
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00008 · Cited by 180
Christen, W. G., Glynn, R. J., Chew, E. Y., Albert, C. M., & Manson, J. E. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.574 · Cited by 180
Cobalt: Its Role in Health and Disease
Yamada, K. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_9 · Cited by 181
Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease
Kaul, S., Zadeh, A. A., & Shah, P. K. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.086 · Cited by 176
ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing
Hickey, S. E., Curry, C. J., & Toriello, H. V. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.165 · Cited by 175
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. A., Friday, G. H., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182112cc2 · Cited by 173
Stanger, O., Fowler, B., Piertzik, K., Huemer, M., Haschke‐Becher, E., Semmler, A., Lorenzl, S., & Linnebank, M. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.75 · Cited by 173
Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets
Fu, Y., Wang, X., & Kong, W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13988 · Cited by 171
Lifestyle modifications for preventing and treating heart failure
Aggarwal, M., Bozkurt, B., Panjrath, G., Aggarwal, B., Ostfeld, R. J., Barnard, N. D., Gaggin, H., Freeman, A. M., Allen, K., Madan, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2160 · Cited by 162
Homocysteine: Its Possible Emerging Role in At-Risk Population Groups
Azzini, E., Ruggeri, S., & Polito, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041421 · Cited by 164
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE)
Chertow, G. M., Pupim, L. B., Block, G. A., Correa‐Rotter, R., Drüeke, T. B., Floege, J., Goodman, W. G., London, G. M., Mahaffey, K. W., Moe, S. M., et al. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04381206 · Cited by 158
The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases
Obeid, R., McCaddon, A., & Herrmann, W. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.356 · Cited by 158
B-Vitamins and Exercise: Does Exercise Alter Requirements?
Woolf, K., & Manore, M. M. (2006) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.16.5.453 · Cited by 164
Folic Acid Supplementation in Patients with Elevated Homocysteine Levels
Kaye, A. D., Jeha, G. M., Pham, A. D., Fuller, M. C., Lerner, Z. I., Sibley, G. T., Cornett, E. M., Urits, I., Viswanath, O., & Kevil, C. G. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01474-z · Cited by 158
No Association Between the Common MTHFR 677C→T Polymorphism and Venous Thrombosis
Bezemer, I. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.5.497 · Cited by 158
Homocysteine Imbalance: a Pathological Metabolic Marker
Schalinske, K. L., & Smazal, A. L. (2012) · Advances in Nutrition · doi:10.3945/an.112.002758 · Cited by 157
Zhong, J., Karlsson, O., Wang, G., Li, J., Guo, Y., Lin, X., Zemplenyi, M., Sánchez-Guerra, M., Trevisi, L., Urch, B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618545114 · Cited by 159
Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention
Lee, M., Hong, K., Chang, S., & Saver, J. L. (2010) · Stroke · doi:10.1161/strokeaha.109.573410 · Cited by 154
Nutrition and human health from a sex–gender perspective
Marino, M., Masella, R., Bulzomi, P., Campesi, I., Malorni, W., & Franconi, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.02.001 · Cited by 159
Antoniades, C. A., Shirodaria, C. C., Leeson, P., Baarholm, O., Van-Assche, T., Cunnington, C., Pillai, R. G., Ratnatunga, C., Tousoulis, D., Stefanadis, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808675 · Cited by 151
Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease
Gutiérrez, O. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02640310 · Cited by 151
Homocysteine, B-vitamins and CVD
McNulty, H., Pentieva, K. D., Hoey, L., & Ward, M. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108007076 · Cited by 151
Randomized Multicenter Investigation of Folate Plus Vitamin B 12 Supplementation in Schizophrenia
Roffman, J. L., Lamberti, J. S., Achtyes, E. D., Macklin, E. A., Galendez, G. C., Raeke, L. H., Silverstein, N. J., Smoller, J. W., Hill, M. B., & GOFF, D. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.900 · Cited by 150
Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Li, H., & Förstermann, U. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058002 · Cited by 154
Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults
Sechi, G., Sechi, E., Fois, C., & Kumar, N. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuv107 · Cited by 149
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis
Malerba, M., Gisondi, P., Radaeli, A., Sala, R., Calzavara‐Pinton, P., & Girolomoni, G. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07503.x · Cited by 146
Limitations of Observational Evidence: Implications for Evidence-Based Dietary Recommendations
Maki, K. C., Slavin, J. L., Rains, T. M., & Kris‐Etherton, P. M. (2014) · Advances in Nutrition · doi:10.3945/an.113.004929 · Cited by 150
Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus
Dunkler, D. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9051 · Cited by 144
Yang, Q.-H., Botto, L. D., Gallagher, M. L., Friedman, J. M., Sanders, C., Koontz, D. A., Nikolova, S. R., Erickson, J. D., & STEINBERG, K. K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.232 · Cited by 143
Yang, Q., Carter, H. K., Mulinare, J., Berry, R., Friedman, J. M., & Erickson, J. D. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1409 · Cited by 143
Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing
Porter, K. M., Hoey, L., Hughes, C., Ward, M., & McNulty, H. (2016) · Nutrients · doi:10.3390/nu8110725 · Cited by 150
B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease
Heinz, J., Kropf, S., Domröse, U., Westphal, S., Borucki, K., Luley, C. H., Neumann, K. H., & Dierkes, J. (2010) · Circulation · doi:10.1161/circulationaha.109.904672 · Cited by 140
Folic Acid Supplementation and Cancer Risk: Point
Kim, Y. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2557 · Cited by 142
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke
Spence, J. D. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.003 · Cited by 141
“[55] Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al.”
BackgroundDoes a High Folate Intake Increase the Risk of Breast Cancer?
Kim, Y. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00178.x · Cited by 134
Folic acid supplementation in pregnancy and implications in health and disease
Barua, S., Kuizon, S., & Junaid, M. A. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0077-z · Cited by 136
Hypercoagulable States in Cardiovascular Disease
Chan, M. Y., Andreotti, F., & Becker, R. C. (2008) · Circulation · doi:10.1161/circulationaha.108.778837 · Cited by 134
2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack
Wang, Y., Liu, M., & Pu, C. (2017) · International Journal of Stroke · doi:10.1177/1747493017694391 · Cited by 134
Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach
Trenor, C. C., Chung, R. J., Michelson, A. D., Neufeld, E. J., Gordon, C. M., Laufer, M. R., & Emans, S. J. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2221 · Cited by 134
Dalmeijer, G. W., Olthof, M. R., Verhoef, P., Bots, M. L., & van der Schouw, Y. T. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602725 · Cited by 131
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski, H. (2008) · PubMed · Cited by 129
B vitamins in stroke prevention: time to reconsider
Spence, J. D., Yi, Q., & Hankey, G. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30180-1 · Cited by 130
More than skin deep: atherosclerosis as a systemic manifestation of psoriasis
ALEXANDROFF, A. B., Pauriah, M., Camp, R. D. R., Lang, C. C., Struthers, A. D., & Armstrong, D. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09281.x · Cited by 131
Sun, A., Chen, H., Cheng, S., Wang, Y., Chang, J. Y., Wu, Y., & Chiang, C. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12241 · Cited by 129
Global Improvement of Vascular Function and Redox State With Low-Dose Folic Acid
Shirodaria, C. C., Antoniades, C. A., Lee, J., Jackson, C. E., Robson, M. D., Francis, J. M., Moat, S. J., Ratnatunga, C., Pillai, R. G., Refsum, H., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.679084 · Cited by 131
Price, B. R., Wilcock, D. M., & Weekman, E. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00350 · Cited by 128
Spence, J. D. (2019) · Nutrients · doi:10.3390/nu11030647 · Cited by 141
“In the same issue of the New England Journal of Medicine, the HOPE-2 trial [50] reported a significant 23% reduction of stroke with B vitamins, but the authors,”
BackgroundColon cancer in Chile before and after the start of the flour fortification program with folic acid
Hirsch, S., Hugo Sánchez, R., Cecilia Albala, B., de la Maza, M. P., Barrera, G., Leiva, L., & Bunout, D. C. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328306ccdb · Cited by 126
Hustad, S., Midttun, Ø., Schneede, J., Vollset, S. E., Grotmol, T., & Ueland, P. M. (2007) · The American Journal of Human Genetics · doi:10.1086/513520 · Cited by 128
Carluccio, M. A., Ancora, M. A., Massaro, M., Carluccio, M., Scoditti, E., Distante, A., Storelli, C., & Caterina, R. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00432.2007 · Cited by 132
Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism
Ray, J. G., Kearon, C., Yi, Q., Sheridan, P., Lonn, E., & for the Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00157 · Cited by 127
Zhou, J., & Austin, R. C. (2009) · BioFactors · doi:10.1002/biof.17 · Cited by 125
Groner, J. A., Joshi, M. S., & Bauer, J. A. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2992 · Cited by 122
Herrmann, M., Peter Schmidt, J., Umanskaya, N., Wagner, A., Taban-Shomal, O., Widmann, T., Colaianni, G., Wildemann, B., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.362 · Cited by 124
Nutrition and Cardiovascular Disease
Getz, G. S., & Reardon, C. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155853 · Cited by 123
Nutrition impacts the prevalence of peripheral arterial disease in the United States
Lane, J. S., Magno, C. P., Lane, K. T., Chan, T. W., Hoyt, D. B., & Greenfield, S. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.05.014 · Cited by 123
Li, J., Li, Q., Du, H., Wang, Y., You, S., Wang, F., Xu, X., Cheng, J. G., Cao, Y., Liu, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160612560 · Cited by 123
Is Vitamin B12 Deficiency a Risk Factor for Cardiovascular Disease in Vegetarians?
Pawlak, R. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.02.009 · Cited by 125
Dhonukshe-Rutten, R. A. M., de Vries, J. H. M., de Bree, A., van der Put, N., van Staveren, W. A., & de Groot, C. P. G. M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602897 · Cited by 124
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., & Grodstein, F. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26404 · Cited by 114
Heine-Bröring, R. C., Winkels, R. M., Renkema, J. M. S., Kragt, L., van Orten-Luiten, A. C. B., Tigchelaar, E. F., Chan, D. S. M., Norat, T., & Kampman, E. (2014) · International Journal of Cancer · doi:10.1002/ijc.29277 · Cited by 121
Kuśmierek, K., Chwatko, G., Głowacki, R., Kubalczyk, P., & Bald, E. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.10.035 · Cited by 122
Huang, T., Chen, Y., Yang, B., Yang, J., Wahlqvist, M. L., & Li, D. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.01.003 · Cited by 122
Zhang, D., Fang, P., Jiang, X., Nelson, J., Moore, J. K., Kruger, W. D., Berretta, R. M., Houser, S. R., Yang, X., & Wang, H. (2012) · Circulation Research · doi:10.1161/circresaha.112.269472 · Cited by 122
Ferreira, G. A., Navarro, T. P., Telles, R. W., Andrade, L. E. C., & Sato, E. I. (2007) · Rheumatology · doi:10.1093/rheumatology/kem186 · Cited by 120
Metadata
- Authors
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-13
- Volume
- 354
- Issue
- 15
- Pages
- 1567-1577
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2109544293
- Cited by
- 1,729
- References
- 20
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 33 · 2023: 30 · 2022: 43 · 2021: 37 · 2020: 52 · 2019: 46 · 2018: 46 · 2017: 70 · 2016: 81 · 2015: 77 · 2014: 84 · 2013: 85 · 2012: 104
- FWCI
- 136.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Massachusetts Medical Society
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- homocysteine lowering, folic acid, vitamin B6, vitamin B12, vascular disease, cardiovascular events, stroke, myocardial infarction, cardiovascular mortality, unstable angina, diabetes mellitus, older adults
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Vascular Diseases, Vitamin B 12, Hyperhomocysteinemia, Stroke, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review